All News

It may difficult to arrive at a diagnosis in cases of acute pain.

Issues with work-life balance, reimbursement, and time are contributors.

Despite counseling, a patient is reluctant to follow her MFM specialist's advice.

Contemporary OB/GYN's blogger on residency discusses the annual survey and the need to have balance in life.

The American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine (SMFM) have released updated guidelines for clinicians caring for women of reproductive age amidst the Zika virus outbreak.

A self-sampling device being used in Canada is receiving high marks from patients.

Geographic factors predict likelihood of HPV vaccine initiation rates, a study finds.

A new update on Zika virus and pregnant women was shared during an ad-hoc session at the 36th SMFM Pregnancy Meeting in Atlanta, Georgia.

Following a normal delivery, a woman develops an infection that leads to severe consequences. Plus: Another case alleging scarring from forceps.

Do women suffer from more migraines as they transition into menopause? Plus: A report indicates that hospitals may not be adequately supporting breastfeeding in teenaged mothers. And, a look at prenatal exposure to bronchodilators and autism.

Dr Greenberg test drives 2 new products to see if they can be of use in your practice.

A commentary on ACOG Practice Bulletin Number 152: Emergency Contraception by Paula J Adams Hillard, MD

On November 11, 2015, the Brazilian Ministry of Health declared a public emergency precipitated by reports of a 10-fold higher rate of fetal microcephaly occurring in these same Zika-affected states.

A retrospective study examines if postterm pregnancies increase the risk of neonatal morbidity, even in low risk pregnancies. Plus: What's the impact of maternal consumption of fish during pregnancy on the child's brain development?

When a case has unfortunate outcomes, obstetrical team members feel unsettled. Not only has an unanticipated, undesired outcome occurred for the patient and family, but team members also may question whether they did everything possible.

The verdicts and settlements involved in this case and 8 others.

A January 4th action by the US Food and Drug Administration (FDA) reclassified transvaginal mesh implants for pelvic organ prolapse (POP) as class III (or high-risk) medical devices requiring premarket approval application (PMA).

The study was designed for tight control of the usual variables.

If proven effective, the vaccine, called VGX-3100, would be the first non-ablative therapy for cervical precancer.

In high-risk patients, use of ultrasound for prenatal diagnosis of this anomaly can enable cesarean delivery and avoid rupture of fetal vessels.

A prospective cohort study looked at a possible link.

A population-based retrospective cohort study by researchers from Oregon is adding new data to the ongoing debate about the safety of giving birth outside of the hospital versus in the hospital.

This mosquito-borne virus is linked with microcephaly, but causation is still being investigated.

The organization finalizes the guidelines that were met with debate when they were first announced in 2015.

A new study examines the breast cancer risk for women who survived childhood cancer. Plus: Should doctors be more careful about using fluconazole during pregnancy? And, do elderly women derive benefit from breast cancer screening?

Dr Lockwood reflects on the potential challenges of 2016.

Surgical mesh for pelvic organ prolapse (POP) is a class III or high-risk medical device requiring premarket approval application (PMA) following new action by the Food and Drug Administration (FDA).

Did it occur during surgery, or did a later injury lead to it?